Lanjia Lin
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
-
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 5
-
- Hepatitis C virus research 7
- Hepatitis Viruses Studies and Epidemiology 2
- Co-authors
- Anuj Gaggar (6 shared papers)G. Mani Subramanian (4 shared papers)John G. McHutchison (3 shared papers)Edward Gane (3 shared papers)Wendy Verret (2 shared papers)Florence Dalenc (2 shared papers)Rosemary Delaney (2 shared papers)Sara M. Tolaney (2 shared papers)
- Journals
- Journal of Hepatology (4 papers)Journal of Clinical Oncology (3 papers)Hepatology International (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Biometrics (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Lanjia Lin
12 papers receiving 707 citations
Lanjia Lin's Hit Papers
Peers
Comparison fields: 5 of 62
- Hepatology 354
- Epidemiology 409
- Oncology 225
- Pulmonary and Respiratory Medicine 137
- Infectious Diseases 74
Countries citing papers authored by Lanjia Lin
This map shows the geographic impact of Lanjia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanjia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanjia Lin more than expected).
Fields of papers citing papers by Lanjia Lin
This network shows the impact of papers produced by Lanjia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanjia Lin. The network helps show where Lanjia Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanjia Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Hit paper breakdown → | 2022 | 176 |
| 2 | 2016 | 141 | |
| 3 | 2014 | 115 | |
| 4 | 2022 | 81 | |
| 5 | 2014 | 80 | |
| 6 | 2015 | 51 | |
| 7 | 2018 | 39 | |
| 8 | 2009 | 17 | |
| 9 | 2017 | 14 | |
| 10 | 2022 | 2 | |
| 11 | Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB) | 2015 | 1 |
| 12 | 2017 | 1 | |
| 13 | 2023 | 0 |
About Lanjia Lin
Lanjia Lin is a scholar working on Epidemiology, Hepatology, Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 13 papers that have together received 718 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (2 papers), HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Hepatitis Viruses Studies and Epidemiology (2 papers) and Statistical Methods and Bayesian Inference (1 paper). The work is most often cited by research in Hepatology (354 citations), Epidemiology (409 citations), Oncology (225 citations), Pulmonary and Respiratory Medicine (137 citations) and Infectious Diseases (74 citations). Lanjia Lin has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Edward Gane, Wendy Verret, Florence Dalenc, Rosemary Delaney, Sara M. Tolaney, Delphine Loirat and Komal Jhaveri. Their work appears in journals such as Journal of Hepatology, Journal of Clinical Oncology, Hepatology International, Antimicrobial Agents and Chemotherapy and Biometrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.